BNP Paribas Financial Markets
ZYME icon

BNP Paribas Financial Markets’s Zymeworks ZYME Stock Holding History

BNP Paribas Financial Markets’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$607K Sell
23,229
-4,890
-17% -$124K ﹤0.01% 3646
2026
Q1 		$704K Buy
28,119
+4,821
+21% +$114K ﹤0.01% 3388
2025
Q4 		$613K Buy
23,298
+7,838
+51% +$171K ﹤0.01% 3457
2025
Q3 		$264K Buy
15,460
+5,153
+50% +$73.8K ﹤0.01% 3877
2025
Q2 		$129K Buy
10,307
+6,307
+158% +$75.1K ﹤0.01% 3930
2025
Q1 		$47.6K Sell
4,000
-3,363
-46% -$45.9K ﹤0.01% 4304
2024
Q4 		$108K Buy
+7,363
New +$103K ﹤0.01% 4140
2022
Q2 		– Sell
-286,928
Closed -$1.88M – 4283
2022
Q1 		$1.88M Buy
286,928
+177,647
+163% +$1.58M ﹤0.01% 1864
2021
Q4 		$1.79M Buy
109,281
+108,584
+15,579% +$2.26M ﹤0.01% 2135
2021
Q3 		$20.2K Buy
697
+55
+9% +$1.83K ﹤0.01% 3638
2021
Q2 		$22.3K Buy
642
+290
+82% +$9.2K ﹤0.01% 3508
2021
Q1 		$11.1K Buy
352
+279
+382% +$11.3K ﹤0.01% 3823
2020
Q4 		$3.45K Buy
+73
New +$3.39K ﹤0.01% 3980

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Rubric Capital Management (New York)
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BVF Inc
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

BNP Paribas Financial Markets's ZYME Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Zymeworks (ZYME) stake by 17% in Q2 2026, selling an estimated $124K and leaving 23,229 shares worth $607K. The position accounts for ﹤0.01% of the portfolio, ranked #3646.

BNP Paribas Financial Markets first reported a position in ZYME in Q4 2020 and has held it in 13 quarters since. The position peaked at $1.88M in Q1 2022. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • BNP Paribas Financial Markets held 23,229 shares of Zymeworks worth $607K as of Q2 2026.
  • BNP Paribas Financial Markets sold 4,890 Zymeworks shares in Q2 2026, an estimated $124K.
  • Zymeworks made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3646 holding.
  • BNP Paribas Financial Markets first reported a position in Zymeworks in Q4 2020 and has held it in 13 quarters since.
  • BNP Paribas Financial Markets's Zymeworks position peaked at $1.88M in Q1 2022.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.